BLOG keyboard_arrow_right FEATURED ARTICLE

Journal Citation Reports 2022: COVID-19 research continues to drive increased citation impact

Today we release the 2022 update to the annual Journal Citation Reports (JCR)™. This year’s release demonstrates the enormous impact the COVID-19 pandemic has had on scholarly publishing. We also identify and define a new type of anomalous citation beh …

Dr Nandita Quaderi
Editor-in-Chief & Vice President Editorial, Web of Science
Clarivate
Intellectual Property
June 30, 2022

Top 100 New Brands in 2022
Robert Reading
Director, Government & Content Strategy
Clarivate
Intellectual Property
June 29, 2022

IP and R&D partnership key to empowering innovation
Vasheharan Kanesarajah
Head of Strategic Development, Intellectual Property
Clarivate
Academia and Government
June 29, 2022

How to find the right journal for your research (using actual data)
Intellectual Property
June 28, 2022

Metaverse and non-fungible tokens (NFTs): what they mean for IP
Brian King
Head of Policy and Advocacy, Intellectual Property Group
Clarivate
Academia and Government
June 28, 2022

Journal Citation Reports 2022: COVID-19 research continues to drive increased citation impact
Dr Nandita Quaderi
Editor-in-Chief & Vice President Editorial, Web of Science
Clarivate
Life Sciences and Healthcare
June 23, 2022

Antibody drug conjugates and bispecifics seize the spotlight at ASCO 2022
Rachel Webster
Head of Oncology and Biosimilars
Clarivate
Intellectual Property
June 23, 2022

Insights on antineoplastic and immunomodulating therapies patent landscape to drive litigation strategy
Eric Sergheraert
Global head of litigation content curation
Clarivate
Academia and Government
June 21, 2022

Journal Citation Reports 2022: A preview
Marie McVeigh
Head of Editorial Integrity, Web of Science
Clarivate
Academia and Government
June 14, 2022

Global collaboration for climate change prevention
Ross Potter
Senior Data Scientist
Clarivate
Clarivate Insights
June 9, 2022

Quality education: Ensuring a sustainable future for intellectual property [World IP Day 2022]
Aman Gata-Aura
Strategy Manager
Clarivate
Life Sciences and Healthcare
May 26, 2022

How a “fail fast” approach can set clinical trials up for success
Matthew Arnold
Principal Analyst
Clarivate
Academia and Government
May 26, 2022

Literature review: your definitive guide
Clarivate Insights
May 24, 2022

Amplifying our strategic commitments to sustainability worldwide
Tiffani Shaw
Chief of Staff, Office of the CEO
Clarivate
Life Sciences and Healthcare
May 24, 2022

For rare disease patients in Mainland China, hope of greater access to treatment
Samantha Wang
Analyst
Clarivate
Academia and Government
May 19, 2022

The future of research in Ukraine is under threat
Gali Halevi
Director at the Institute for Scientific Information
Clarivate